Ayal Rozenberg

407 total citations
16 papers, 226 citations indexed

About

Ayal Rozenberg is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Ayal Rozenberg has authored 16 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 5 papers in Neurology. Recurrent topics in Ayal Rozenberg's work include Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (5 papers) and Polyomavirus and related diseases (4 papers). Ayal Rozenberg is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (5 papers) and Polyomavirus and related diseases (4 papers). Ayal Rozenberg collaborates with scholars based in Israel, United States and Canada. Ayal Rozenberg's co-authors include Rui Li, Moffat Nyirenda, Amit Bar‐Or, Ayman Rezk, Jeffrey A. Cohen, Jane Reese, Antonio Uccelli, Marie‐Noëlle Boivin, Peter J. Darlington and Farzaneh Jalili and has published in prestigious journals such as Brain, Frontiers in Immunology and British Journal of Haematology.

In The Last Decade

Ayal Rozenberg

15 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayal Rozenberg Israel	8	89	78	61	39	39	16	226
François Jacques Canada	6	52 0.6×	59 0.8×	23 0.4×	40 1.0×	27 0.7×	16	202
Jennifer Massey Australia	9	80 0.9×	173 2.2×	22 0.4×	34 0.9×	94 2.4×	23	282
Alice Willison Germany	9	22 0.2×	90 1.2×	43 0.7×	45 1.2×	25 0.6×	17	210
Seyed Mohammad Baghbanian Iran	9	32 0.4×	132 1.7×	21 0.3×	32 0.8×	20 0.5×	43	236
Vivien Li Australia	9	31 0.3×	102 1.3×	10 0.2×	30 0.8×	23 0.6×	23	194
Swantje Mindorf Germany	6	24 0.3×	65 0.8×	23 0.4×	48 1.2×	14 0.4×	7	323
Carolina Rush Canada	8	35 0.4×	252 3.2×	16 0.3×	41 1.1×	85 2.2×	17	314
Rintaro Ohe Japan	10	52 0.6×	43 0.6×	38 0.6×	81 2.1×	74 1.9×	42	250
Ciro Florio Italy	8	107 1.2×	142 1.8×	6 0.1×	45 1.2×	43 1.1×	12	270
Sebastiano Arena Italy	7	49 0.6×	190 2.4×	9 0.1×	34 0.9×	82 2.1×	10	270

Countries citing papers authored by Ayal Rozenberg

Since Specialization

Citations

This map shows the geographic impact of Ayal Rozenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayal Rozenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayal Rozenberg more than expected).

Fields of papers citing papers by Ayal Rozenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayal Rozenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayal Rozenberg. The network helps show where Ayal Rozenberg may publish in the future.

Co-authorship network of co-authors of Ayal Rozenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Ayal Rozenberg. A scholar is included among the top collaborators of Ayal Rozenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayal Rozenberg. Ayal Rozenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Rozenberg, Ayal, Shahar Shelly, Riva Fineman, et al.. (2025). CCR5 predicts neurotoxicity in CAR‐T‐cell therapy. British Journal of Haematology. 207(3). 1133–1137. 1 indexed citations

Ganelin‐Cohen, Esther, Adi Vaknin‐Dembinsky, Mark A. Hellmann, et al.. (2024). The effect of COVID‐19 vaccination on multiple sclerosis activity as reflected by MRI. Brain and Behavior. 14(7). e3587–e3587.

Rozenberg, Ayal, et al.. (2024). Cognitive impairments in autoimmune encephalitis: the role of autoimmune antibodies and oligoclonal bands. Frontiers in Immunology. 15. 1405337–1405337. 4 indexed citations

Rozenberg, Ayal, et al.. (2024). Primary CNS vasculitis: insights into clinical, neuropathological, and neuroradiological characteristics. Frontiers in Neurology. 15. 1363985–1363985. 1 indexed citations

Rozenberg, Ayal, et al.. (2024). Long term survival and outcomes in patients with paraneoplastic neurologic syndromes. Frontiers in Immunology. 15. 1466704–1466704. 2 indexed citations

Ganelin‐Cohen, Esther, et al.. (2023). Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implications. Multiple Sclerosis and Related Disorders. 79. 105034–105034. 7 indexed citations

Brill, Livnat, et al.. (2022). Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine. Multiple Sclerosis and Related Disorders. 63. 103863–103863. 4 indexed citations

Ganelin‐Cohen, Esther, et al.. (2022). Personalized Disease Monitoring in Pediatric Onset Multiple Sclerosis Using the Saliva Free Light Chain Test. Frontiers in Immunology. 13. 5 indexed citations

Nyirenda, Moffat, Giulia Fadda, Luke M. Healy, et al.. (2021). Pro-inflammatory adiponectin in pediatric-onset multiple sclerosis. Multiple Sclerosis Journal. 27(12). 1948–1959. 12 indexed citations

10.

Brill, Livnat, Ariel Rechtman, Omri Zveik, et al.. (2021). Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 57. 103343–103343. 14 indexed citations

11.

Ganelin‐Cohen, Esther, et al.. (2020). Alemtuzumab mediates the CD39⁺ T‐regulatory cell response via CD23⁺ macrophages. Immunology and Cell Biology. 99(5). 521–531. 6 indexed citations

12.

Mexhitaj, Ina, Moffat Nyirenda, Rui Li, et al.. (2019). Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis. Brain. 142(3). 617–632. 61 indexed citations

13.

Ganelin‐Cohen, Esther, et al.. (2018). Search for new biomarkers of pediatric multiple sclerosis: application of immunoglobulin free light chain analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 56(7). 1081–1089. 7 indexed citations

14.

Eran, Ayelet, et al.. (2018). MRI in predicting conversion to multiple sclerosis within 1 year. Brain and Behavior. 8(9). e01042–e01042. 10 indexed citations

15.

Rozenberg, Ayal, Ayman Rezk, Marie‐Noëlle Boivin, et al.. (2016). Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism. Stem Cells Translational Medicine. 5(11). 1506–1514. 76 indexed citations

16.

Sadan, Ofer, M. Y. Neufeld, Yisrael Parmet, Ayal Rozenberg, & Svetlana Kipervasser. (2015). Psychogenic seizures: long-term outcome in patients with and without epilepsy. Acta Neurologica Scandinavica. 133(2). 145–151. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact